Biomatter Raises $18M Series A Led by Astanor to Scale AI Enzyme Design for Food and Industrial Biomanufacturing
Vilnius-based Biomatter has closed an oversubscribed $18M Series A led by agrifood investor Astanor to build a 2,000 m² enzyme design-and-testing facility, expand in the US and scale AI-designed enzymes for customers including Kirin, Tereos, BASF and Sanofi.



















